26.11.98 Official Journal of the European Communities L 317/47 COMMISSION DECISION of 17 November 1998 recognising in principle the completeness of the dossiers submitted for detailed examination in view of the possible inclusion of KIF 3535 (mepanipyrim), imazamox (AC 299263), DE 570 (florasulam), fluazolat (JV 485), Coniothyrium minitans and benzoic acid in Annex I to Council Directive 91/414/EEC concerning the placing of plant-protection products on the market (notified under document number C(1998) 3514) (Text with EEA relevance) (98/676/EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant-protection products on the market ('), as last amended by Commis- sion Directive 98/47/EC (*) and in particular Article 6(3) thereof, Whereas Directive 91/414/EEC (hereinafter ‘the Direct- ive’) has provided for the development of a Community list of active substances authorised for incorporation in plant protection products; Whereas applicants have submitted dossiers for six active substances to Member States’ authorities in view of obtaining the inclusion of the active substances in Annex I to the Directive; Whereas a dossier for the active substance KIF 3535 (mepanipyrim) was submitted by Kumiai Chemical Industry Co. Ltd to the Italian authorities on 24 October 1997, Whereas a dossier for the active substance imazamox (AC 299263) was submitted by Cyanamid Agro SA/NV to the French authorities on 2 December 1997; Whereas a dossier for the active substance DE 570 (flora- sulam) was submitted by Dow Agro Sciences to the Belgian authorities on 2 February 1998; Whereas a dossier for the active substance fluazolat (JV 485) was submitted by Twinagro Ltd to the United Kingdom authorities on 29 September 1997; Whereas a dossier for the active substance Coniothyrium minitans was submitted by Prophyta GmbH to the German authorities on 10 September 1997; Whereas a dossier for the active substance benzoic acid was submitted by Menno Chemie Vertriebsgesellschaft mbH to the German authorities on 25 May 1998; 230, 19. 8. 1991, p. 1. 191, 7. 7. 1998, p. 50. 00 =< onll o Whereas the said authorities indicated to the Commission the results of a first examination of the completeness of the dossier with regard to the data and information requirements provided for in Annex II and, for at least one plant protection product containing the active substance concerned, in Annex III to the Directive; whereas subsequently, in accordance with the provisions of Article 6(2), the dossiers were submitted by the appli- cant to the Commission and other Member States; Whereas the dossiers for KIF 3535 (mepanipyrim), imazamox (AC 299263), DE 570 (florasulam), fluazolat (JV 485), Coniothyrium minitans and benzoic acid were referred to the Standing Committee on Plant Health on 7 July 1998; Whereas Article 6(3) of the Directive requires it being confirmed at the level of the Community that each dossier is to be considered as satisfying in principle the data and information requirements provided for in Annex II and, for at least one plant protection product containing the active substance concerned, in Annex III to the Directive; Whereas such confirmation is necessary in order to pursue the detailed examination of the dossier as well as in order to open to Member States the possibility of granting provisional authorisation for plant protection products containing this active substance in due respect of the conditions laid down in Article 8(1) of the Direct- ive, and in particular the condition to make a detailed assessment of the active substances and the plant protec- tion products with regard to the requirements of the Directive; Whereas such Decision does not prejudice that further data or information may be requested from the applicant where it would appear during the detailed examination that such information or data are required for a Decision to be taken; Whereas it is understood between the Member States and the Commission that Italy will pursue the detailed exam- ination for the dossier for KIF 3535 (mepanipyrim), that France will pursue the detailed examination for the dossier for imazamox (AC 299263), that Belgium will pursue the detailed examination for the dossier for DE